Stem Cell Therapy for Osteoporosis

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2014 Jan 11

PMID 24407712

Citations 57

Authors

Ben Antebi

Gadi Pelled

Dan Gazit

Affiliations

Soon will be listed here.

Abstract

Osteoporosis is a debilitating disease that affects millions of people worldwide. Current osteoporosis treatments are predominantly bone-resorbing drugs that are associated with several side effects. The use of stem cells for tissue regeneration has raised great hope in various fields of medicine, including musculoskeletal disorders. Stem cell therapy for osteoporosis could potentially reduce the susceptibility of fractures and augment lost mineral density by either increasing the numbers or restoring the function of resident stem cells that can proliferate and differentiate into bone-forming cells. Such osteoporosis therapies can be carried out by exogenous introduction of mesenchymal stem cells (MSCs), typically procured from bone marrow, adipose, and umbilical cord blood tissues or through treatments with drugs or small molecules that recruit endogenous stem cells to osteoporotic sites. The main hurdle with cell-based osteoporosis therapy is the uncertainty of stem cell fate and biodistribution following cell transplantation. Therefore, future advancements will focus on long-term engraftment and differentiation of stem cells at desired bone sites for tangible clinical outcome.

Citing Articles

FoxA1 knockdown promotes BMSC osteogenesis in part by activating the ERK1/2 signaling pathway and preventing ovariectomy-induced bone loss.

Li L, Lin R, Xu Y, Li L, Pan Z, Huang J Sci Rep. 2025; 15(1):4594.

PMID: 39920313 PMC: 11806018. DOI: 10.1038/s41598-025-88658-1.

miR-21-5p Enriched Exosomes from Human Embryonic Stem Cells Promote Osteogenesis via YAP1 Modulation.

Huang X, Zhao Z, Zhan W, Deng M, Wu X, Chen Z Int J Nanomedicine. 2024; 19:13095-13112.

PMID: 39660279 PMC: 11629668. DOI: 10.2147/IJN.S484751.

Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness.

Kim T, Kim H Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139844 PMC: 10747168. DOI: 10.3390/ph16121718.

Mesenchymal stem cell-derived apoptotic bodies alleviate alveolar bone destruction by regulating osteoclast differentiation and function.

Li X, Jiang Y, Liu X, Fu J, Du J, Luo Z Int J Oral Sci. 2023; 15(1):51.

PMID: 38040672 PMC: 10692139. DOI: 10.1038/s41368-023-00255-y.

Glia maturation factor beta deficiency protects against diabetic osteoporosis by suppressing osteoclast hyperactivity.

Shi S, Gu H, Xu J, Sun W, Liu C, Zhu T Exp Mol Med. 2023; 55(5):898-909.

PMID: 37121966 PMC: 10238439. DOI: 10.1038/s12276-023-00980-8.

References

Wang Z, Goh J, Das De S, Ge Z, Ouyang H, Chong J . Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng. 2006; 12(7):1753-61. DOI: 10.1089/ten.2006.12.1753. View

Nieves J, Cosman F . Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep. 2010; 8(1):34-9. DOI: 10.1007/s11914-010-0007-2. View

Guan M, Yao W, Liu R, Lam K, Nolta J, Jia J . Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med. 2012; 18(3):456-62. PMC: 3755884. DOI: 10.1038/nm.2665. View

Cummings S, San Martin J, McClung M, Siris E, Eastell R, Reid I . Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009; 361(8):756-65. DOI: 10.1056/NEJMoa0809493. View

Steinert A, Rackwitz L, Gilbert F, Noth U, Tuan R . Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med. 2012; 1(3):237-47. PMC: 3659848. DOI: 10.5966/sctm.2011-0036. View

Cho S, Sun H, Yang J, Jung J, An J, Cho H . Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther. 2009; 17(11):1979-87. PMC: 2835036. DOI: 10.1038/mt.2009.153. View

Levi B, Longaker M . Concise review: adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells. 2011; 29(4):576-82. PMC: 3323288. DOI: 10.1002/stem.612. View

Kim D, Cho S, Her S, Yang J, Kim S, Kim S . Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. Stem Cells. 2006; 24(7):1798-805. DOI: 10.1634/stemcells.2005-0480. View

Canalis E, Giustina A, Bilezikian J . Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007; 357(9):905-16. DOI: 10.1056/NEJMra067395. View

10.

Elabd S, Sabry I, Hassan W, Nour H, Zaky K . Possible neuroendocrine role for oxytocin in bone remodeling. Endocr Regul. 2008; 41(4):131-41. View

11.

Lien C, Chih-Yuan Ho K, Lee O, Blunn G, Su Y . Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 2008; 24(5):837-48. DOI: 10.1359/jbmr.081257. View

12.

Tang Y, Tang W, Lin Y, Long J, Wang H, Liu L . Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. Cell Biol Int. 2008; 32(9):1150-7. DOI: 10.1016/j.cellbi.2008.06.005. View

13.

Ma L, Makino Y, Yamaza H, Akiyama K, Hoshino Y, Song G . Cryopreserved dental pulp tissues of exfoliated deciduous teeth is a feasible stem cell resource for regenerative medicine. PLoS One. 2012; 7(12):e51777. PMC: 3522596. DOI: 10.1371/journal.pone.0051777. View

14.

Weinstein R, Roberson P, Manolagas S . Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med. 2009; 360(1):53-62. PMC: 2866022. DOI: 10.1056/NEJMoa0802633. View

15.

Hsiao F, Cheng C, Peng S, Huang H, Lian W, Jan M . Isolation of therapeutically functional mouse bone marrow mesenchymal stem cells within 3 h by an effective single-step plastic-adherent method. Cell Prolif. 2010; 43(3):235-48. PMC: 6496704. DOI: 10.1111/j.1365-2184.2010.00674.x. View

16.

Lane N . Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006; 194(2 Suppl):S3-11. DOI: 10.1016/j.ajog.2005.08.047. View

17.

Sethe S, Scutt A, Stolzing A . Aging of mesenchymal stem cells. Ageing Res Rev. 2005; 5(1):91-116. DOI: 10.1016/j.arr.2005.10.001. View

18.

Barrett-Connor E, Mosca L, Collins P, Geiger M, Grady D, Kornitzer M . Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006; 355(2):125-37. DOI: 10.1056/NEJMoa062462. View

19.

Cooper C, Campion G, Melton 3rd L . Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992; 2(6):285-9. DOI: 10.1007/BF01623184. View

20.

Vertenten G, Lippens E, Girones J, Gorski T, Declercq H, Saunders J . Evaluation of an injectable, photopolymerizable, and three-dimensional scaffold based on methacrylate-endcapped poly(D,L-lactide-co-epsilon-caprolactone) combined with autologous mesenchymal stem cells in a goat tibial unicortical defect model. Tissue Eng Part A. 2008; 15(7):1501-11. DOI: 10.1089/ten.tea.2008.0367. View